Skip to main content

Table 2 Response to immunotherapy

From: Alpha-fetoprotein predicts the treatment efficacy of immune checkpoint inhibitors for gastric cancer patients

Response

Total No.

Low AFP group

High AFP group

P

PD

27

17

10

 

SD

105

99

6

 

PR

25

21

4

 

CR

1

1

0

 

ORR

16.5% (95% CI: 10.6-22.3%)

15.9% (95% CI: 10.5-23.6%)

20% (95% CI: 0.8-39.2%)

0.995

DCR

82.9% (95% CI: 77.0-88.8%)

87.7% (95% CI: 82.1-93.2%)

50% (95%CI: 26.0-74.0%)

0.000

  1. CR: complete response; PR: partial response; SD: stable disease; PD: progressive disease; DCR: disease control rate; ORR: objective response rate; AFP: alpha-fetoprotein
Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us